Home › Metastatic Cancer › Indiana
Metastatic Cancer clinical trials in Indiana
23 studies for Metastatic Cancer are looking for participants at sites in Indiana.
Cities in Indiana
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
- UChicago Medicine Northwest Indiana, Crown Point
- Woodland Cancer Care Center, Michigan City
RecruitingPhase 2
All ages · All sexes · Updated Nov 12, 2026 · NCT05564377LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC
- Parkview Packnett Family Cancer Institute, Fort Wayne
- Franciscan Health Indianapolis, Indianapolis
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 10, 2026 · NCT06216301A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
- Indiana University Health University Hospital, Indianapolis
- Hematology Oncology of Indiana, Indianapolis
- Deaconess GI Specialty Center, Newburgh
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 4, 2026 · NCT07174336A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
- IU Simon Cancer Center, Indianapolis
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Nov 4, 2026 · NCT06465069A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
- Indiana University Melvin and Bren Simon Cancer Center, Indianapolis
- Franciscan Health, Indianapolis
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 4, 2026 · NCT07213804A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
- Parkview Research Center at Parkview Regional Medical Center, Fort Wayne
- Indiana University Melvin and Bren Simon Cancer Center, Indianapolis
- Franciscan Health, Indianapolis
- and 1 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 4, 2026 · NCT06119581FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
- Indiana University (IU) Melvin and Bren Simon Cancer Center, Indianapolis
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Nov 4, 2026 · NCT05614739A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
- Community Health Network, Indianapolis
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Oct 22, 2026 · NCT04657068AMG 436 as Monotherapy and Combination Therapy in Participants With MSI-H/dMMR Solid Tumors
- Community Health Network MD Anderson Cancer Center - North, Indianapolis
RecruitingPhase 1
Ages 18 to 99 · All sexes · Updated Oct 20, 2026 · NCT07403721A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors
- Northwest Cancer Centers, Dyer
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Oct 19, 2026 · NCT06244771Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
- Community Health Network, Inc, Indianapolis
- Community Health Network, Inc., Indianapolis
- Community Health Network, Inc., Indianapolis
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 8, 2026 · NCT07222566Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
- Franciscan Health, Indianapolis
- Franciscan Health Mooresville, Mooresville
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 8, 2026 · NCT07222800A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
- Parkview Research Center at Parkview Regional Medical Center, Fort Wayne
- Indiana University Melvin and Bren Simon Cancer Center, Indianapolis
- Franciscan Health, Indianapolis
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 7, 2026 · NCT07218380A Study of Dato-DXd in Inoperable or Metastatic Hormone Receptor-positive, HER2 IHC 0 Breast Cancer
- Research Site, Fort Wayne
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 2, 2026 · NCT07205822Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
- Indiana University Simon Comprehensive Cancer Center, Indianapolis
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Oct 1, 2026 · NCT06625775Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
- Community Health Network, Indianapolis
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT06128551Prospective Validation of a Points Score System Predicting 30-day Survival
- IU Health West, Avon
- IU Health North / Schwarz Cancer Center, Carmel
- Methodist Hospital, Indianapolis
RecruitingObservational study
Ages 18 and older · All sexes · Updated Sep 17, 2026 · NCT05100342A Study of IDP-001 in Advanced or Metastatic Solid Tumors
- Community Cancer Center North, Indianapolis
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 3, 2026 · NCT07602842Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
- Northwest Cancer Center, Dyer
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 2, 2026 · NCT06072612Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)
- Research Site, Fort Wayne
- Research Site, Indianapolis
RecruitingPhase 3
Ages 18 and older · Women · Updated Jul 29, 2026 · NCT07044336Evaluating Disparities in Precision Oncology
- Indiana University Health Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis
RecruitingObservational study
Ages 18 and older · All sexes · Updated Jun 16, 2026 · NCT06081517Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer
- Fort Wayne Medical Oncology and Hematology, Fort Wayne
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Apr 1, 2026 · NCT05735080A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer
- First Urology, Jeffersonville
RecruitingPhase 1
Ages 18 and older · Men · Updated Feb 4, 2026 · NCT04729114From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.